| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Shen Li, Ying Gao, Hao Lv, Miaomiao Zhang, Lili Wang, Rui Jiang, Chengai Xu, Xueshi Wang, Ming Gao, Yukun He, Jie Li, Wei-Dong L. T Psychoneuroendocrinology. vol 88. 2018-12-31. PMID:29175720. |
in this study, 264 han chinese inpatients diagnosed with schizophrenia or schizoaffective disorder initiated treatment with olanzapine (n=131) or risperidone (n=133) and were followed for 12weeks. |
2018-12-31 |
2023-08-13 |
Not clear |
| Lourdes Anta, Jordi Llaudó, Ignacio Ayani, Javier Martínez, Robert E Litman, Ibón Gutierr. A phase II study to evaluate the pharmacokinetics, safety, and tolerability of Risperidone ISM multiple intramuscular injections once every 4 weeks in patients with schizophrenia. International clinical psychopharmacology. vol 33. issue 2. 2018-12-19. PMID:29112001. |
a phase ii study to evaluate the pharmacokinetics, safety, and tolerability of risperidone ism multiple intramuscular injections once every 4 weeks in patients with schizophrenia. |
2018-12-19 |
2023-08-13 |
Not clear |
| Alireza Ghajar, Mohammad-Reza Khoaie-Ardakani, Zahara Shahmoradi, Amir-Reza Alavi, Mohsen Afarideh, Mohammad-Reza Shalbafan, Maryam Ghazizadeh-Hashemi, Shahin Akhondzade. L-carnosine as an add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: A double-blind, randomized placebo-controlled trial. Psychiatry research. vol 262. 2018-12-11. PMID:29427913. |
l-carnosine as an add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: a double-blind, randomized placebo-controlled trial. |
2018-12-11 |
2023-08-13 |
Not clear |
| Ming Teng Koh, Paige S Ahrens, Michela Gallaghe. A greater tendency for representation mediated learning in a ketamine mouse model of schizophrenia. Behavioral neuroscience. vol 132. issue 2. 2018-12-11. PMID:29672108. |
chronic treatment with the antipsychotic drug, risperidone, in ketamine-exposed mice attenuated mediated learning, a finding that may be related to its known efficacy in reducing the positive symptoms of schizophrenia. |
2018-12-11 |
2023-08-13 |
mouse |
| Rong-Qin Wu, Chong-Guang Lin, Wei Zhang, Xiao-Dong Lin, Xing-Shi Chen, Ce Chen, Li-Jun Zhang, Zi-Ye Huang, Guang-Dong Chen, Da-Li Xu, Zhi-Guang Lin, Ming-Dao Zhan. Effects of Risperidone and Paliperidone on Brain-Derived Neurotrophic Factor and N400 in First-Episode Schizophrenia. Chinese medical journal. vol 131. issue 19. 2018-12-11. PMID:30246715. |
effects of risperidone and paliperidone on brain-derived neurotrophic factor and n400 in first-episode schizophrenia. |
2018-12-11 |
2023-08-13 |
Not clear |
| Rong-Qin Wu, Chong-Guang Lin, Wei Zhang, Xiao-Dong Lin, Xing-Shi Chen, Ce Chen, Li-Jun Zhang, Zi-Ye Huang, Guang-Dong Chen, Da-Li Xu, Zhi-Guang Lin, Ming-Dao Zhan. Effects of Risperidone and Paliperidone on Brain-Derived Neurotrophic Factor and N400 in First-Episode Schizophrenia. Chinese medical journal. vol 131. issue 19. 2018-12-11. PMID:30246715. |
risperidone and paliperidone have been the mainstay treatment for schizophrenia and their potential role in neuroprotection could be associated with brain-derived neurotrophic factor (bdnf) and n400 (an event-related brain potential component). |
2018-12-11 |
2023-08-13 |
Not clear |
| Rong-Qin Wu, Chong-Guang Lin, Wei Zhang, Xiao-Dong Lin, Xing-Shi Chen, Ce Chen, Li-Jun Zhang, Zi-Ye Huang, Guang-Dong Chen, Da-Li Xu, Zhi-Guang Lin, Ming-Dao Zhan. Effects of Risperidone and Paliperidone on Brain-Derived Neurotrophic Factor and N400 in First-Episode Schizophrenia. Chinese medical journal. vol 131. issue 19. 2018-12-11. PMID:30246715. |
this study aimed to compare the effects of risperidone and paliperidone on bdnf and the n400 component of the event-related brain potential in patients with first-episode schizophrenia. |
2018-12-11 |
2023-08-13 |
Not clear |
| Marise W J Machielsen, Dick J Veltman, Wim van den Brink, Lieuwe de Haa. Comparing the effect of clozapine and risperidone on cue reactivity in male patients with schizophrenia and a cannabis use disorder: A randomized fMRI study. Schizophrenia research. vol 194. 2018-11-13. PMID:28351544. |
comparing the effect of clozapine and risperidone on cue reactivity in male patients with schizophrenia and a cannabis use disorder: a randomized fmri study. |
2018-11-13 |
2023-08-13 |
Not clear |
| Narjes Hendouei, Samaneh Farnia, Farhad Mohseni, Azadeh Salehi, Maedeh Bagheri, Faezeh Shadfar, Fatemeh Barzegar, Seyed Davood Hoseini, Jamshid Yazdani Charati, Fatemeh Shak. Alterations in oxidative stress markers and its correlation with clinical findings in schizophrenic patients consuming perphenazine, clozapine and risperidone. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. vol 103. 2018-11-13. PMID:29710513. |
therefore, in this study, we evaluated the level of oxidative stress parameters between patients treated with perphenazine, clozapine and risperidone and their relationship with schizophrenia symptoms' severity. |
2018-11-13 |
2023-08-13 |
Not clear |
| Ming Teng Koh, Yi Shao, Sharon Rosenzweig-Lipson, Michela Gallaghe. Treatment with levetiracetam improves cognition in a ketamine rat model of schizophrenia. Schizophrenia research. vol 193. 2018-11-09. PMID:28634087. |
levetiracetam remained effective when administered concurrently with risperidone, supporting potential viability of adjunctive therapy with levetiracetam to treat cognitive deficits in schizophrenia patients under concurrent antipsychotic therapy. |
2018-11-09 |
2023-08-13 |
rat |
| Maju Mathews, Huiling Pei, Adam Savitz, Isaac Nuamah, David Hough, Larry Alphs, Srihari Gopa. Paliperidone Palmitate 3-Monthly Versus 1-Monthly Injectable in Patients With Schizophrenia With or Without Prior Exposure to Oral Risperidone or Paliperidone: A Post Hoc, Subgroup Analysis. Clinical drug investigation. vol 38. issue 8. 2018-11-09. PMID:29882073. |
paliperidone palmitate 3-monthly versus 1-monthly injectable in patients with schizophrenia with or without prior exposure to oral risperidone or paliperidone: a post hoc, subgroup analysis. |
2018-11-09 |
2023-08-13 |
Not clear |
| Ying Chen, Yang Deng, Miao Yan, Zhenyan Hou, Yao Li, Bikui Zhang, Hualin Ca. Genotyping as a Key Element of Sample Size Optimization in Bioequivalence of Risperidone Tablets. European journal of drug metabolism and pharmacokinetics. vol 43. issue 4. 2018-10-23. PMID:29404931. |
risperidone is a derivative of benzisoxazole and is widely used for schizophrenia and other psychiatric illnesses in both adults and children. |
2018-10-23 |
2023-08-13 |
Not clear |
| Xiao-Jia Jiang, Fu-Xi Wu, Jian-Ping Zhang, Lei Shi, Jin-Qing Hu, Hai-Zhen Zhu, Bing Xiao, Wei-Cheng Lin, Yu-Guan Wen, De-Wei Shan. Effects of Risperidone and Aripiprazole on Serum Levels of Prolactin, Testosterone and Estradiol in Female Patients with Schizophrenia. Drug research. vol 68. issue 7. 2018-10-18. PMID:29482256. |
effects of risperidone and aripiprazole on serum levels of prolactin, testosterone and estradiol in female patients with schizophrenia. |
2018-10-18 |
2023-08-13 |
Not clear |
| Xiao-Jia Jiang, Fu-Xi Wu, Jian-Ping Zhang, Lei Shi, Jin-Qing Hu, Hai-Zhen Zhu, Bing Xiao, Wei-Cheng Lin, Yu-Guan Wen, De-Wei Shan. Effects of Risperidone and Aripiprazole on Serum Levels of Prolactin, Testosterone and Estradiol in Female Patients with Schizophrenia. Drug research. vol 68. issue 7. 2018-10-18. PMID:29482256. |
to evaluate the effects of treatment with risperidone and aripiprazole on serum prolactin, testosterone and estradiol levels in female patients with schizophrenia in china. |
2018-10-18 |
2023-08-13 |
Not clear |
| Li-Juan Gao, Hua-Gui Guo, Zhen-Tao Liang, Xiao-Xiao Zhong, Jin-Cai Zhu, Yu Yan. [Aripiprazole for drug-induced sexual dysfunction in schizophrenic males]. Zhonghua nan ke xue = National journal of andrology. vol 23. issue 7. 2018-10-12. PMID:29723454. |
to investigate the clinical effects of aripiprazole on sexual dysfunction induced by amisulpride or risperidone in male patients with schizophrenia. |
2018-10-12 |
2023-08-13 |
Not clear |
| Alain Bruno Tagne Nouemss. Risperidone-associated sinus tachycardia potentiated by paliperidone palmitate in a patient with no prior cardiovascular disease: role of risperidone-related autonomic instability. BMJ case reports. vol 2018. 2018-10-11. PMID:29680794. |
risperidone and paliperidone palmitate are two antipsychotic drugs well tolerated in the management of schizophrenia and other psychiatric conditions. |
2018-10-11 |
2023-08-13 |
Not clear |
| Lei Zeng, ChuanYuan Kang, Jing Yuan, Yan Zhang, YuJun Wei, Li Xu, Fang Zhou, JianZhong Yan. CYP2D6 polymorphisms are associated with effects of risperidone on neurocognitive performance in schizophrenia. Schizophrenia research. vol 188. 2018-10-02. PMID:28131599. |
cyp2d6 polymorphisms are associated with effects of risperidone on neurocognitive performance in schizophrenia. |
2018-10-02 |
2023-08-13 |
Not clear |
| Anna Dietrich-Muszalska, Jolanta Kolińska-Łukaszu. Comparative effects of aripiprazole and selected antipsychotic drugs on lipid peroxidation in plasma. Psychiatry and clinical neurosciences. vol 72. issue 5. 2018-09-28. PMID:29280533. |
the aim of the present study was to evaluate and compare the effects of a new antipsychotic, aripiprazole (unique due to its mechanism of action), with the effects of selected antipsychotic drugs, such as quetiapine, olanzapine, clozapine, risperidone, and ziprasidone (at the final concentrations corresponding to clinically effective doses used for the treatment of acute episodes of schizophrenia) on lipid peroxidation in human plasma measured by the level of thiobarbituric acid reactive substances (tbars), which is a marker of oxidative stress. |
2018-09-28 |
2023-08-13 |
human |
| Shuang-min Ji, An-ning Li, Fang Dong, Liang Li, Tian-yan Zhou, Chuan-yue Wang, Wei L. [Using the cumulative odds Logit model to explore the application of the questionnaire derived from PANSS]. Yao xue xue bao = Acta pharmaceutica Sinica. vol 51. issue 10. 2018-08-21. PMID:29932602. |
currently, aripiprazole, olanzapine and risperidone are three anti-psychiatry agents commonly used in the treatment of schizophrenia. |
2018-08-21 |
2023-08-13 |
Not clear |
| Alireza Haji Seyed Javadi, Ali Akbar Shafikhani, Seyed Mohsen Zamir, Zahra Farzane Khanshi. Evaluation of the Effect of Fluvoxamine in Patients With Schizophrenia Under Risperidone Treatment: A Clinical Trial. Journal of clinical psychopharmacology. vol 38. issue 2. 2018-08-15. PMID:29432331. |
evaluation of the effect of fluvoxamine in patients with schizophrenia under risperidone treatment: a clinical trial. |
2018-08-15 |
2023-08-13 |
Not clear |